Comparing Fludeoxyglucose F18–PET Assessment of Regional Cerebral Glucose Metabolism and [11C]Dihydrotetrabenazine–PET in Evaluation of Early Dementia and Mild Cognitive Impairment

VA Ann Arbor Health System Geriatrics Research, Education, and Clinical Center, and Department of Neurology, University of Michigan, Ann Arbor, MI 48109-2200, USA.
Archives of neurology (Impact Factor: 7.42). 04/2010; 67(4):440-6. DOI: 10.1001/archneurol.2010.34
Source: PubMed


To compare assessment of regional cerebral metabolic changes with [(11)C]dihydrotetrabenazine (DTBZ)-positron emission tomography (PET) measurement of regional cerebral blood flow (K(1)) and fludeoxyglucose F18 (FDG)-PET measurement of regional cerebral glucose uptake (CMR(glc)) in a clinically representative sample of subjects with mild dementia and mild cognitive impairment (MCI).
[(11)C]Dihydrotetrabenazine-PET K(1) and FDG-PET CMR(glc) measurements were performed.
University-based cognitive disorders clinic.
Fifty subjects with either mild dementia (Mini-Mental State Examination score > or = 18) or MCI. Their results were compared with those of 80 normal control subjects.
The DTBZ-PET regional K(1) and FDG-PET CMR(glc) measurements were compared with standard correlation analysis. The overall patterns of DTBZ-PET K(1) and FDG-PET CMR(glc) deficits were assessed with stereotaxic surface projections (SSPs) of parametric images.
The DTBZ-PET regional K(1) and FDG-PET CMR(glc) measurements were highly correlated, both within and between subjects. The SSP maps of deficits in DTBZ-PET regional K(1) and FDG-PET CMR(glc) measurements were markedly similar. The DTBZ-PET K(1) SSP maps exhibited a mild decrease in sensitivity relative to FDG-PET CMR(glc) maps.
Both DTBZ-PET K(1) and FDG-PET CMR(glc) measurements provide comparable information in assessment of regional cerebral metabolic deficits in mild dementia and MCI. Blood flow measures can assess regional cerebral metabolism deficits accurately in mild dementia and MCI. Blood flow assessments of regional cerebral metabolic deficits can be combined with tracer binding results to improve utility of PET imaging in mild dementia and MCI.

Download full-text


Available from: James F Burke, Nov 07, 2014
  • Source
    • "Assessing the cerebral glucose metabolism using [ 18 F]FDG-PET, assumedly AD-and MCIrelated reductions of cerebral glucose metabolism were reported for AD-typical regions, but not in all studies. Albin et al. (2010) found 18% (anterior cingulate cortex), 16% (frontal cortex), 14% (parietal cortex), 13% (temporal cortex, medial frontal cortex), 11% (amygdala, parahippocampus , insula), 9% (posterior cingulate cortex), and 8% (medial temporal cortex) reductions in a mixed large sample of patients with dementia or MCI as compared with healthy controls. Jhoo et al. (2010) found an 8.1% reduction in the hippocampus of patients with AD as compared with age-and gender-matched healthy controls and no difference between controls and MCI. "

    Full-text · Article · Sep 2009 · Pharmacopsychiatry
  • [Show abstract] [Hide abstract]
    ABSTRACT: Summary form only given. Balanced receivers with large bandwidths can be used in intensity-modulated (IM) lightwave systems or in continuous phase frequency shift-keyed (CPFSK) lightwave systems. In the IM system, they can be used at the receiver to obtain a duobinary encoded signal at the preamplifier output. In a coherent CPFSK system, the balanced receiver can improve the receiver sensitivity by 3 dB. With data rates in excess of one gigabit per second, both IM and CPFSK lightwave systems will require large bandwidth GaAs MESFET MMIC preamplifiers that have associated problems of high-frequency noise.
    No preview · Conference Paper · Jan 1996
  • [Show abstract] [Hide abstract]
    ABSTRACT: [(18)F]fluorodeoxyglucose positron emission tomography ([(18)F]FDG-PET) is a well-established method for the examination of the cerebral glucose metabolism of patients with affective disorder or memory impairment. An understudied question is how far results are influenced by interindividual differences in central nervous arousal as assessed with electroencephalogram (EEG-vigilance) during the PET recording. Building upon previous neuroimaging studies, we supposed an association between EEG-vigilance and normalized brain [(18)F]FDG-uptake (nFDGu) as measured by [(18)F]FDG-PET. For the first time, the present study exploratively investigated this association in a routine diagnostic work-up. Simultaneous 31-channel EEG and [(18)F]FDG-PET under resting conditions were acquired from 14 patients with depressive episode or mild cognitive impairment (MCI). EEG-vigilance was automatically classified by using the VIGALL algorithm (Vigilance Algorithm Leipzig). A nonparametric voxelwise simple linear regression with vigilance measure as predictor and nFDGu as criterion was performed using the Statistical nonParametric Mapping toolbox. The main finding was a significant negative correlation between vigilance measure and nFDGu in bilateral frontal and temporal regions, bilateral cingulate gyrus and right thalamus with vigilance-related changes of nFDGu between 17.1 and 44.4%. Simultaneous EEG and [(18)F]FDG-PET under resting conditions revealed that brain regions associated with EEG-vigilance partly overlapped with regions of impaired nFDGu in depression and MCI, as reported by previous studies. Vigilance-related changes of nFDGu were about the same magnitude as disease-related metabolic changes in patients with affective disorder or memory impairment as reported in previous studies. Therefore, our data suggest that differences in EEG-vigilance might influence alterations of nFDGu in disorders such as depression or MCI. Whether this possible impact of vigilance on nFDGu should be taken into account during the routine diagnostic application of [(18)F]FDG-PET has to be explored in future studies with larger patient groups.
    No preview · Article · May 2011 · NeuroImage
Show more